In a significant step towards advancing precision oncology and building future-ready healthcare talent, SRM Institute of Science and Technology (SRMIST) has signed a Memorandum of Understanding (MoU) with CORE Diagnostics, a global leader in cancer diagnostics and genomic testing.
With cancer care increasingly moving towards personalised and precision-based treatment, expertise in genetic diagnostics and next-generation sequencing is becoming indispensable. This partnership is designed to bridge the gap between classroom learning and real-world oncology practice, providing students with direct exposure to cutting-edge diagnostic technologies, genetic counseling frameworks and industry-led research.
The MoU is expected to significantly enhance student competitiveness in the rapidly evolving healthcare sector. By working alongside industry experts and engaging with advanced genomic technologies, students will graduate not only with academic knowledge but with applied clinical insight, a crucial differentiator in today’s job market. Beyond training, the collaboration also opens avenues for joint research initiatives aimed at advancing cancer diagnostics and improving patient outcomes.
As oncology treatment continues to evolve towards data-driven, individualised care, this SRMIST–CORE Diagnostics partnership signals a forward-looking commitment to strengthening India’s healthcare talent ecosystem ensuring that the next generation of professionals is equipped to lead in precision medicine and cancer care innovation.
